SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants

Adoptive T-cell immunotherapy has provided promising results in the treatment of viral complications in humans, particularly in the context of immunocompromised patients who have exhausted all other clinical options. The capacity to expand T cells from healthy immune individuals is providing a new a...

Descripción completa

Detalles Bibliográficos
Autores principales: Panikkar, Archana, Lineburg, Katie E., Raju, Jyothy, Chew, Keng Yih, Ambalathingal, George R., Rehan, Sweera, Swaminathan, Srividhya, Crooks, Pauline, Le Texier, Laetitia, Beagley, Leone, Best, Shannon, Solomon, Matthew, Matthews, Katherine K., Srihari, Sriganesh, Neller, Michelle A., Short, Kirsty R., Khanna, Rajiv, Smith, Corey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880869/
https://www.ncbi.nlm.nih.gov/pubmed/35157735
http://dx.doi.org/10.1371/journal.ppat.1010339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880869/
https://www.ncbi.nlm.nih.gov/pubmed/35157735
http://dx.doi.org/10.1371/journal.ppat.1010339

Ejemplares similares